Sign in

CIK 0001907108 · <br>Emerging growth company

Lexeo Therapeutics, Inc.

Sign in to watch
Ticker
LXEO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
854012572
Phone
(212) 547-9879
Business address
345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$43,228
in 3 filings

Net −$43,228. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Tamayo Louis Edward −$20K Chief Financial Officer sold 4% of stake
  2. Townsend Richard Nolan −$17K Chief Executive Officer sold <1% of stake
  3. Otero Jose Manuel −$6K Chief Operating Officer sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2024-02-02 DIAZ REINALDO M Director Grant or award · Stock Option (right to buy) +36,000 36,000
2024-02-02 Agger Mette Kirstine Director Grant or award · Stock Option (right to buy) +36,000 36,000
2024-02-02 Adler Eric Chief Medical Officer Grant or award +26,875 26,875
2024-02-02 Adler Eric Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +161,250 161,250
2024-01-05 Townsend Richard Nolan Chief Executive Officer Grant or award 10b5-1 +43,750 170,695
2024-01-05 Townsend Richard Nolan Chief Executive Officer Grant or award · Stock Option (Right to Buy) 10b5-1 +262,500 262,500
2024-01-05 Robertson Jenny Chief Legal and Admin Officer Grant or award 10b5-1 +23,750 23,750
2024-01-05 Robertson Jenny Chief Legal and Admin Officer Grant or award · Stock Option (Right to Buy) 10b5-1 +142,500 142,500
2023-11-07 Omega Fund VI, L.P. 10% owner Conversion +1,415,865 1,415,865
2023-11-07 Omega Fund VI, L.P. 10% owner Conversion +287,213 1,703,078
2023-11-07 Omega Fund VI, L.P. 10% owner Purchase +454,545 $11.00 $5.0M 2,157,623
2023-11-07 Omega Fund VI, L.P. 10% owner Conversion · Series A convertible preferred stock −14,999,999 0
2023-11-07 Omega Fund VI, L.P. 10% owner Conversion · Series B convertible preferred stock −2,615,533 0
2023-11-07 McCormac Paul Chief Technical Officer Conversion +3,191 17,349
2023-11-07 McCormac Paul Chief Technical Officer Conversion · Series B convertible preferred stock −29,061 0
2023-11-07 Lundbeckfond Invest A/S 10% owner Conversion +1,321,474 1,321,474
2023-11-07 Lundbeckfond Invest A/S 10% owner Conversion +287,213 1,608,687
2023-11-07 Lundbeckfond Invest A/S 10% owner Purchase +227,272 $11.00 $2.5M 1,835,959
2023-11-07 Lundbeckfond Invest A/S 10% owner Conversion · Series A convertible preferred stock −13,999,999 0
2023-11-07 Lundbeckfond Invest A/S 10% owner Conversion · Series B convertible preferred stock −2,615,533 0

Page 8 of 9 · 165 trades